Dr. Matthias Kling is a professor in Photon Science and Applied Physics and the Director of the Science, Research and Development division at LCLS at SLAC. This division also hosts a Biosciences Department with a focus on ultrafast X-ray imaging and spectroscopy.
Dr. Matthias Garten is an assistant professor in the department of Immunology and Microbiology and the department of Bioengineering. He is a membrane biophysicist who is driven by the question of how the malaria parasite interfaces with its host-red blood cell, how we can use the unique mechanisms of the parasite to treat malaria and to re-engineer cells for biomedical applications.
Dr. Matthew Wheeler is a physician scientist with interests in cardiomyopathies, rare and undiagnosed diseases, therapeutics and genomics. Dr. Wheeler has research training in both myocardial and skeletal muscle biology and genetics, genomics, and multi-scale networks and is a physician with interest and experience treating patients with hypertrophic cardiomyopathy and other inherited cardiomyopathies. I have clinical training in medicine, cardiology, cardiovascular genetics, and advanced heart failure.
The Bogyo Lab is interested in developing and applying chemical tools to both image and dissect the functional roles of hydrolases in a number of human health conditions. They are currently using synthetic chemistry and biological display methods to build new covalent binding probes that allow enzyme activity to be selectively inhibited as well as imaged in complex biological samples including cells, tissues and whole organisms. The Bogyo lab is specifically interested in hydrolase enzymes important for cell signaling and pathogenesis in cancer and various microbes including S.
Dr. Matt Hernandez received his MD/PhD from the Icahn School of Medicine at Mount Sinai (ISMMS) in New York City. His graduate work focused on viral-host interactions and tracing HIV evolution in vivo using genomic tools. During his training, he applied his skills to the clinical laboratory and helped found the ISMMS Personalized Virology Initiative.
